Proteus Digital Health gets $50 million in Series H
April 15, 2016 – REDWOOD CITY. Leading Digital Medicine company Proteus Digital Health announced today it has secured $50 million in Series H financing. This investment further strengthens the company’s balance sheet and provides capital to expand the world’s first Digital Medicine platform.The company plans to drive increased adoption of Proteus Discover®, the company’s initial service offering, by partnering with health system customers to further demonstrate the outcomes that can be achieved with Digital Medicines. The additional capital expands the company’s investor base and underscores progress made since closing its previous Series G financing in 2014.
“This financing demonstrates confidence in our Digital Medicine platform and deliberate, staged approach to market building,” said Andrew Thompson, President and Chief Executive Officer of Proteus Digital Health. “We are at the forefront of the digital transformation of healthcare, and are excited to work with our customers, partners and investors to help lead the way.”
Digital Medicine offerings, such as Proteus Discover, consist of a sensor-enabled pill, a small wearable patch, and applications that can be accessed via mobile devices and other computers by patients and healthcare providers. Proteus Discover directly measures medication-taking and physiologic metrics to support patient self-management and to help physicians and care teams optimize therapy.
Source: Proteus Digital Health